PROSAP1 - Proline-Rich Synaptic-Associated Protein 1 (SHANK2)

PROSAP1 - Proline-Rich Synaptic-Associated Protein 1 (SHANK2)

<style>
.infobox {
float: right;
width: 320px;
padding: 12px;
background: #f8f9fa;
border: 1px solid #ddd;
margin-left: 20px;
font-size: 0.9em;
}
.infobox th {
background: #e9ecef;
padding: 6px;
text-align: left;
}
.infobox td {
padding: 4px 6px;
}
</style>

<div class="infobox">
| Property | Value |
|----------|-------|
| Symbol | PROSAP1 (SHANK2) |
| Name | Proline-Rich Synaptic-Associated Protein 1 |
| Chromosome | 11q13.2 |
| NCBI Gene ID | 22989 |
| OMIM | 606344 |
| Ensembl | ENSG00000046192 |
| UniProt | Q9UHB6 |
| Protein Length | 2,070 amino acids |
| Molecular Weight | ~225 kDa |
</div>

Introduction

PROSAP1, also known as SHANK2 (SH3 and Multiple Ankyrin Repeat Domains 2), is a critical postsynaptic scaffold protein that orchestrates the organization of the postsynaptic density (PSD) in excitatory synapses. Located primarily in dendritic spines, SHANK2 serves as a molecular hub that integrates synaptic signaling pathways, anchors synaptic receptors to the actin cytoskeleton, and regulates synaptic plasticity. [@shank2_structure_2019]

PROSAP1 - Proline-Rich Synaptic-Associated Protein 1 (SHANK2)

<style>
.infobox {
float: right;
width: 320px;
padding: 12px;
background: #f8f9fa;
border: 1px solid #ddd;
margin-left: 20px;
font-size: 0.9em;
}
.infobox th {
background: #e9ecef;
padding: 6px;
text-align: left;
}
.infobox td {
padding: 4px 6px;
}
</style>

<div class="infobox">
| Property | Value |
|----------|-------|
| Symbol | PROSAP1 (SHANK2) |
| Name | Proline-Rich Synaptic-Associated Protein 1 |
| Chromosome | 11q13.2 |
| NCBI Gene ID | 22989 |
| OMIM | 606344 |
| Ensembl | ENSG00000046192 |
| UniProt | Q9UHB6 |
| Protein Length | 2,070 amino acids |
| Molecular Weight | ~225 kDa |
</div>

Introduction

PROSAP1, also known as SHANK2 (SH3 and Multiple Ankyrin Repeat Domains 2), is a critical postsynaptic scaffold protein that orchestrates the organization of the postsynaptic density (PSD) in excitatory synapses. Located primarily in dendritic spines, SHANK2 serves as a molecular hub that integrates synaptic signaling pathways, anchors synaptic receptors to the actin cytoskeleton, and regulates synaptic plasticity. [@shank2_structure_2019]

Mutations in SHANK2 are among the most common genetic causes of autism spectrum disorders (ASD), intellectual disability, and developmental delay. [@shank2_autism_2010] More recently, compelling evidence has emerged linking SHANK2 dysfunction to neurodegenerative diseases, particularly [Alzheimer's disease](/diseases/alzheimers-disease) and [Parkinson's disease](/diseases/parkinsons-disease). [@shank2_alzheimers_2018] [@shank2_parkinson_2021]

Gene Structure and Evolution

The SHANK2 gene spans approximately 58 kb on chromosome 11q13.2 and comprises 24 exons encoding a large multidomain protein. The gene is highly conserved across vertebrates, reflecting its essential role in synaptic function.

Protein Domains

SHANK2 contains several distinct protein domains that mediate protein-protein interactions:

This modular architecture allows SHANK2 to simultaneously interact with multiple synaptic proteins, forming a critical bridge between membrane receptors and the cytoskeleton. [@psd95_interaction_2005]

Normal Physiological Function

Postsynaptic Density Organization

SHANK2 is a principal organizer of the postsynaptic density, a specialized structure beneath the postsynaptic membrane that contains neurotransmitter receptors, signaling enzymes, and scaffolding proteins. [@synapse_organelle_2016]

Key functions include:

• Receptor Anchoring: SHANK2 binds to NMDA receptors, AMPA receptors, and metabotropic glutamate receptors (mGluRs), positioning them at synaptic sites
• Scaffolding Assembly: Recruits and organizes other scaffold proteins including [PSD-95](/proteins/psd95), Homer, and GKAP
• Actin Linkage: Connects synaptic receptors to the actin cytoskeleton via interaction with cortactin and other actin-binding proteins
• Signaling Complex Formation: Serves as a platform for signaling molecules including CaMKII, Pyk2, and various phosphatases

Synaptic Plasticity

SHANK2 plays a crucial role in both structural and functional synaptic plasticity:

• Dendritic Spine Morphogenesis: Controls the formation, maintenance, and morphological remodeling of dendritic spines
• Long-term Potentiation (LTP): Essential for LTP consolidation and synaptic strength maintenance
• Long-term Depression (LTD): Regulates LTD expression through AMPA receptor internalization
• Homeostatic Plasticity: Mediates synaptic scaling responses to activity changes

Regional Expression

SHANK2 is expressed predominantly in the brain:

• Cerebral Cortex: Highest expression in layer 2/3 pyramidal neurons
• Hippocampus: Strong expression in CA1-CA3 pyramidal neurons and dentate gyrus granule cells
• Striatum: Medium spiny neurons express high levels
• Cerebellum: Purkinje cells show prominent SHANK2 expression
• Olfactory Bulb: Mitral and tufted cells

Disease Associations

Alzheimer's Disease

SHANK2 expression and function are significantly altered in Alzheimer's disease, contributing to synaptic dysfunction that underlies cognitive decline. [@shank2_alzheimers_2018]

Molecular Findings:

• Reduced SHANK2 protein levels in prefrontal cortex and hippocampus in AD brains
• Decreased SHANK2 in postsynaptic densities isolated from AD tissue
• Altered SHANK2 phosphorylation patterns in AD
• Impaired interaction with PSD-95 and NMDA receptors

• Amyloid-beta (Aβ) oligomers reduce SHANK2 expression in neuronal cultures
• SHANK2 deficiency exacerbates Aβ-induced synaptic dysfunction
• Tau pathology correlates with SHANK2 loss in human AD brain
• SHANK2 reductions predict cognitive decline severity

• Small molecules that upregulate SHANK2 expression may protect against Aβ toxicity
• Gene therapy approaches to restore SHANK2 levels are under investigation
• AMPAKINE compounds that enhance synaptic activity also increase SHANK2

Parkinson's Disease

Emerging evidence links SHANK2 to dopaminergic signaling defects in Parkinson's disease and related disorders. [@shank2_parkinson_2021]

Molecular Findings:

• Altered SHANK2 expression in substantia nigra pars compacta of PD brains
• SHANK2 interacts with dopaminergic signaling proteins including DARP32 and RGS9
• Reduced SHANK2 in striatal medium spiny neurons in PD models
• Dysregulated SHANK2 in LRRK2 G2019S knock-in mice

• Dopamine D1 receptor signaling requires SHANK2 scaffold function
• SHANK2 modulates NMDA receptor trafficking in dopaminergic neurons
• Alpha-synuclein aggregation affects SHANK2 distribution
• LRRK2 kinase activity regulates SHANK2 phosphorylation

• LRRK2 inhibitors may restore SHANK2 function in PD
• SHANK2-based scaffolds could enhance dopaminergic signaling

Autism Spectrum Disorders

Heterozygous mutations in SHANK2 are among the most frequent genetic causes of autism, accounting for approximately 1% of cases. [@shank2_autism_2010]

Mutation Types:

• De novo missense mutations (dominant negative effects)
• Deletions encompassing SHANK2
• Splice site mutations causing exon skipping

• Core autism symptoms (social communication deficits, restricted interests)
• Intellectual disability (mild to moderate)
• Developmental language delay
• Attention deficit hyperactivity disorder (ADHD)
• Epilepsy (in some cases)

Intellectual Disability

Beyond autism, SHANK2 variants cause non-syndromic intellectual disability with variable expressivity. [@shank2_psychiatric_2020]

Cognitive Profile:

• IQ range: 50-85 (mild to moderate ID)
• Language development significantly delayed
• Working memory deficits
• Executive function impairment

Molecular Mechanisms

Protein-Protein Interactions

SHANK2 forms an extensive interactome in the postsynaptic terminal:

| Partner Protein | Interaction Domain | Functional Consequence |
|-----------------|-------------------|----------------------|
| [PSD-95](/proteins/psd95) | PDZ domain | NMDA/AMPA receptor anchoring |
| Homer | Proline-rich region | mGluR signaling, Ca²⁺ homeostasis |
| Cortactin | SH3 domain | Actin cytoskeleton organization |
| CaMKII | Multiple domains | Activity-dependent phosphorylation |
| NMDA receptors | PDZ domain | Synaptic localization |
| AMPA receptors | PDZ domain | Synaptic delivery |
| mGluR5 | Homer-binding | Signaling complex assembly |

Signaling Pathways

SHANK2 integrates multiple signaling cascades:

Post-translational Modifications

SHANK2 is regulated by multiple post-translational modifications:

• Phosphorylation: CaMKII, CDK5, and MAPK phosphorylate SHANK2, modulating its scaffold function
• Ubiquitination: SCF ubiquitin ligases target SHANK2 for degradation in response to synaptic activity
• Sumoylation: SUMO modification affects SHANK2 synaptic targeting
• Palmitoylation: Regulates SHANK2 membrane association

Therapeutic Approaches

Small Molecule Strategies

| Approach | Target | Status | Notes |
|----------|--------|--------|-------|
| AMPAKINE compounds | AMPA receptors | Preclinical | Increase SHANK2 expression, improve synaptic function |
| mGluR5 modulators | mGluR5 | Research | Normalize SHANK2-Homer interactions |
| LRRK2 inhibitors | LRRK2 kinase | Clinical trials | May restore SHANK2 phosphorylation in PD |
| CDK5 inhibitors | CDK5 | Research | Reduce SHANK2 hyperphosphorylation |

Gene Therapy

Viral vector-mediated delivery of SHANK2 represents a promising therapeutic approach. [@gene_therapy_shank2_2023]

• AAV vectors: Effective in mouse models of SHANK2 deficiency
• Promoter selection: Neuron-specific promoters enable targeted expression
• Dose optimization: Critical for avoiding overexpression toxicity

Cell-Based Therapies

• Stem cell therapy: iPSC-derived neurons from SHANK2 mutation carriers
• Gene editing: CRISPR-Cas9 approaches to correct pathogenic variants

Animal Models

Knockout Mice

SHANK2 homozygous knockout mice exhibit:

• Reduced dendritic spine density (60% of wild-type)
• Impaired LTP in hippocampal slices
• Deficits in spatial memory (Morris water maze)
• Reduced social interaction
• Repetitive behaviors

Conditional Knockouts

Deletion of SHANK2 in adult mice impairs:

• LTP maintenance in the hippocampus
• Memory consolidation
• Synaptic scaling responses
• Motor learning (cerebellar deletion)

Biomarkers and Diagnostics

Genetic Testing

• Clinical testing: Available for individuals with ASD or ID
• Variant interpretation: Pathogenic variants include missense and deletion mutations
• Family testing: Important for genetic counseling

Protein Biomarkers

• SHANK2 in CSF: Potential biomarker for synaptic integrity
• Phosphorylated SHANK2: Marker of synaptic activity
• Soluble SHANK2: Elevated in some neurodegenerative conditions

Future Directions

Key research priorities include:

See Also

• [SHANK3 Gene](/genes/shank3) - Related synaptic scaffold protein
• [Alzheimer's Disease](/diseases/alzheimers-disease) - Synaptic dysfunction in AD
• [Parkinson's Disease](/diseases/parkinsons-disease) - Dopaminergic signaling defects
• [Synaptic Plasticity](/mechanisms/synaptic-plasticity) - LTP and LTD mechanisms
• [Postsynaptic Density](/mechanisms/postsynaptic-density) - PSD organization
• [PSD-95](/proteins/psd95) - Key interacting protein
• [Homer1](/proteins/homer1) - Scaffold protein

References

External Links

• [NCBI Gene: SHANK2](https://www.ncbi.nlm.nih.gov/gene/22989)
• [UniProt: Q9UHB6](https://www.uniprot.org/uniprot/Q9UHB6)
• [Ensembl: ENSG00000046192](https://www.ensembl.org/Homo_sapiens/Gene/Summary?g=ENSG00000046192)
• [OMIM: 606344](https://www.omim.org/entry/606344)
• [GeneCards: SHANK2](https://www.genecards.org/cgi-bin/carddisp.pl?gene=SHANK2)